Log In
Print this Print this

RC48-ADC (RC48)

  Manage Alerts
Collapse Summary General Information
Company Yantai Rongchang Pharmaceutical Co. Ltd.
DescriptionAntibody drug conjugate (ADC)
Molecular Target
Mechanism of ActionAntibody-drug conjugate
Therapeutic ModalityBiologic: Antibody-drug conjugate
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat HER2-expressing advanced solid tumors; Treat solid tumors
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today